¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Hepatitis A Virus Vaccine Inactivated And Hepatitis B Vir..."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® vaccine ÇÑ±Û ¹é½Å
¼³¸í   
  Àü¿°º´¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ÁÖ±â À§ÇØ »ýü¿¡ Åõ¿©Çϴ Ç׿øÀÇ Çϳª. º´¿øÃ¼ ¹× µ¶¼Ò¿¡ ´ëÇÑ ¹æ¾î±â±¸¸¦ °­È­ÇÒ ¸ñÀûÀ¸·Î »ç¿ëµÇ´Â ¹Ì»ý¹°Á¦Á¦¸¦ ¸»ÇÑ´Ù. ÇÁ¶û½ºÀÇ ¹Ì»ý¹°ÇÐÀÚ L. ÆÄ½ºÅ𸣿¡ ÀÇÇÏ¿© Á¦Ã¢µÈ ¿ë¾î·Î¼­, ¾î¶² °¨¿°Áõ¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ¾ò±â À§ÇÏ¿© ±× º´¿ø ¹Ì»ý¹° ¶Ç´Â ±× µ¶¼Ò¾×¿¡ Àû´çÇÑ Á¶ÀÛÀ» °¡ÇÏ¿© ¸¸µç °ÍÀ» ¸»ÇÑ´Ù.
¿µ¹® Dilatation and Curettage(D & C) ÇÑ±Û Àڱñܾ¼ú, ÀڱøñÈ®Àå
¼³¸í   
  ÀÚ±ÃÀ̶õ Å¾ư¡ ¼öŵǾ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇϴ °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ Å¾Ƹ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼­ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇϴ ÀڱøñÀ» È®Àå½ÃÄѾߠÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇϴ ¹ý°ú ¼­¼­È÷ È®ÀåÀ» ½ÃµµÇϴ 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ À־ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼­ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼­¼­È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇϴ ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃʷΠ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î ÃµÃµÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³­´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼­ ÀڱüÓÀÇ º´º¯À̳ª ÀӽŵȠžƸ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀǠäÃë ¹× Á¦°Å¸¦ À§Çؼ­µµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. À̴ ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿­ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù.
¿µ¹® virus ÇÑ±Û ¹ÙÀÌ·¯½º
¼³¸í   
  ¹ÚÅ׸®¾Æº¸´Ù ´ú ÁøÈ­µÈ, »ý¹°°ú ¹«»ý¹°ÀÇ Áß°£´Ü°è¿¡ ÇØ´çÇϴ °Í. È¥ÀÚ¼­´Â »ýÁ¸´É·ÂÀÌ ¾øÀ¸¹Ç·Î ¹Ýµå½Ã ´Ù¸¥ ¼¼Æ÷³»¿¡ ¼ÓÇØ ÀÖ¾î¾ß ÇÑ´Ù. ÀÎü¿¡ ¹ß»ýÇϴ ¸¹Àº º´Áß, ÀÌ ¹ÙÀÌ·¯½º·Î ÀÎÇØ ¹ß»ýÇϴ °æ¿ì°¡ ¸¹À¸¸ç, ÀÌ ¶§ ´ëºÎºÐ Æ¯ÀÌÇÑ Ä¡·á¹ýÀº ¾ø´Â ½ÇÁ¤ÀÌ´Ù. ÀϺΠÇ츣Æä½º¹ÙÀÌ·¯½º °èÅë¿¡´Â Ä¡·á¾àÀÌ °³¹ßµÇ¾î ÀÖÁö¸¸, À̰͵µ ÀϺΠÁúº´¿¡¼­¸¸ Ä¡·á°¡ °¡´ÉÇÏ´Ù. ¶ÇÇÑ, Ebstein-Barr virus, Human papilloma virus µîÀº ¾ÏÀÇ ¹ß»ý°ú ¿¬°üµÇ¾î ÀÖÀ¸¸ç, µ¿¹°¿¡¼­ ¹ß»ýÇϴ ´ëºÎºÐÀÇ ¾ÏÁ¾Àº ¹ÙÀÌ·¯½º¿Í ¿¬°üµÇ¾î Àִ °æ¿ì°¡ ¸¹´Ù. ¿äÁò, ÀϺΠÁö¿ª¿¡¼­ Å« À¯ÇàÀ» Çϰí Àִ ÈÄõ¼º¸é¿ª°áÇÌÁõÈıº(AIDS)µµ HIV(Human Immunodeficiency Virus)¿Í °ü·ÃÀÌ ÀÖ´Ù.
¿µ¹® simian virus ÇÑ±Û ¿ø¼þÀ̹ÙÀÌ·¯½º
¼³¸í   
  ¿ø¼þÀÌ¿¡¼­ ºÐ¸®µÈ ¹ÙÀÌ·¯½º. ¾Æµ¥³ë¹ÙÀÌ·¯½º, ¿£Å׷ιÙÀÌ·¯½º, Ç츣Æä½º¹ÙÀÌ·¯½º ¹× ·¹¿À¹ÙÀÌ·¯½º µîÀÇ ¿©·¯ ±º¿¡ ¼ÓÇÑ´Ù.
¿µ¹® influenza virus ÇÑ±Û ÀÎÇ÷翣ÀÚ¹ÙÀÌ·¯½º
¼³¸í   
  ÀÎÇ÷翣ÀÚÀÇ º´¿øÃ¼. »ó±âµµ Á¡¸·¿¡ Ä§ÀÔÇÏ¿© È£Èí±â ÁúȯÀ» ÀÏÀ¸Å²´Ù. º¸Ã¼ °áÇÕ Ç׿øÀÇ Â÷ÀÌ¿¡ µû¶ó A-B-C ¼¼ÇüÅ·Π³ª´µ¸ç, À¯ÇàÇÒ ¶§¸¶´Ù Ç÷±¸ ÀÀÁý Ç׿øÀÌ º¯ÀÌÇÏ¿© ±¤¹üÀ§ÇÑ À¯ÇàÀ» ³ªÅ¸³½´Ù. ²®ÁúÀÌ Àִ 80~150nmÀÇ °ø¸ð¾ç, ³ª¼± ´ëĪ RNA ¹ÙÀÌ·¯½ºÀÌ´Ù. µÎ Á¾·ùÀÇ ½ºÆÄÀÌÅ©, ´º¶ó¹Ì´Ï´Ù¾ÆÁ¦(neuraminidase, NA), ´ç´Ü¹éÁú°ú Ç츶±Û·çƼ´Ñ(hemagglution, HA) ´ç´Ü¹éÁúÀ» ¸¸µç´Ù. AÇüÀÇ NA¿¡´Â N1-N2ÀÇ µÎ Á¾·ù, HA¿¡´Â HAO-HA1-HA2-HA3ÀÇ ³× Á¾·ù°¡ ÀÖ´Ù. AÇüÀº ¸»-µÅÁö-»õ¿¡ °¨¿°Çϸ砻õ·Î¿î ¾ÆÇüÀº µ¿¹° ¹ÙÀÌ·¯½º¿ÍÀÇ Á¶È¯ÇüÀ̸ç, ±× ¹Û¿¡ µ¿ÀÏ ¾ÆÇü³» Á¡º¯À̰¡ ÀÖ´Ù. B, CÇüÀº »ç¶÷ À̿ܿ¡´Â °¨¿°µÇÁö ¾Ê´Â´Ù. ´ßÀÇ ÀûÇ÷±¸¸¦ ÀÀÁýÇϴ ¼ºÁúÀÌ ÀÖ´Ù. ¹ÙÀÌ·¯½º Áø´Ü¿¡´Â È¯ÀÚÀÇ ÀεΠ¼¼Ã´¾×¿¡¼­ ºÐ¸®ÇѴٵ簡, ¶Ç´Â È¯ÀÚÀÇ Ç÷ûÇ×ü¿¡ ÀÇÇѠƯÀÌÀû ÀûÇ÷±¸ ÀÀÁýÀúÁö°Ë»ç, ´º¶ó¹Ì´Ï´Ù¾ÆÁ¦ È°¼ºÀúÁö°Ë»ç ¶Ç´Â ÁßÈ­°Ë»ç µîÀ¸·Î °ËÃâÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • hepatitis B vaccine
    BÇü°£¿°¹é½Å
  • inactivated serum
    ºñȰ¼ºÈ­Ç÷û
  • hepatitis E virus
    EÇü°£¿°¹ÙÀÌ·¯½º
  • hepatitis G virus
    GÇü°£¿°¹ÙÀÌ·¯½º
  • attenuated vaccine
    ¾à(µ¶)È­¹é½Å, ¾àµ¶¹é½Å
  • human diploid cell vaccine
    »ç¶÷µÎ¹è¼ö¼¼Æ÷¹é½Å
  • killed vaccine
    »ç¸ê¹é½Å, »ç¹é½Å
  • live vaccine
    »ý¹é½Å
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • rabies vaccine
    ±¤°ßº´¹é½Å
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å
  • subunit vaccine
    ¾Æ´ÜÀ§¹é½Å
  • vaccine
    ¹é½Å
  • vaccine rash
    ¹é½Å¹ßÁø
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diphteria and tetanus toxoids and acellular pert vaccine
    °³·®µðÇÇÆ¼
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • kidney ureter and bladder
    ÄáÆÏ¿ä°ü¹æ±¤´Ü¼øÃÔ¿µ
  • dilatation and curettage
    Àڱñܾ¼ú, ÀÚ±Ã¼ÒÆÄ¼ú
  • peritoneal oocyte and sperm transfer
    »ý½Ä¼¼Æ÷º¹°­³»À̽Ä, »ý½Ä¼¼Æ÷º¹°­³»Àü´Þ
  • vaccine
    ¹é½Å
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å, ¾àµ¶¹é½Å
  • killed vaccine
    »ç¸ê¹é½Å, »ç¹é½Å
  • live vaccine
    »ý¹é½Å
  • hepatitis
    °£¿°
  • acute hepatitis
    ±Þ¼º°£¿°
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°
  • serum hepatitis
    Ç÷û°£¿°
  • viral hepatitis
    ¹ÙÀÌ·¯½º°£¿°
  • human papilloma virus test
    »ç¶÷À¯µÎÁ¾¹ÙÀÌ·¯½º°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • live vaccine virus
    »ý¹é½Å¹ÙÀÌ·¯½º
  • inactivated serum
    ºñȰ¼ºÈ­Ç÷û
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å, ¾àµ¶¹é½Å
  • corresponding vaccine
    µ¿Á¾±Õ¹é½Å
  • vaccine exanthem
    Á¾µÎ¹ßÁø
  • internal image vaccine
    ³»ºÎ¿µ»ó¹é½Å, °³º°Æ¯ÀÌÇü¹é½Å
  • killed vaccine
    »ç¸ê¹é½Å
  • live vaccine
    »ý¹é½Å
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å
  • vaccine rash
    ¹é½Å¹ßÁø
  • subunit vaccine
    ¾Æ´ÜÀ§¹é½Å
  • vaccine therapy
    ¹é½Å¿ä¹ý
  • vaccine
    ¹é½Å
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • hoof and mouth disease =foot and mouth d.
    ±¸Á¦(¿ª)(Ï¢ð´æ¹) º´.
  • inactivated serum
    ºñȰ¼ºÈ­Ç÷û.
  • hepatitis A virus(HAV)
    AÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis A virus (HAV)
    AÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis B virus(HBV)
    BÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis C virus(HCV)
    CÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis D virus(HDV)
    DÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis E virus(HEV)
    EÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis F virus(HFV)
    FÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis G virus(HGV)
    GÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis a virus
    AÇü°£¿° ¹ÙÀÌ·¯½º
  • hepatitis b virus
    BÇü°£¿° ¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vaccine, inactivated virus
    ºÒȰ¼ºÈ­ ¹ÙÀÌ·¯½º ¹é½Å
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • inactivated serum
    ºñȰ¼ºÈ­Ç÷û.
  • influenza virus vaccine
    ÀÎÇ÷翣ÀÚ¹ÙÀÌ·¯½º¹é½Å.
  • live vaccine virus
    »ý¹é½Å¹ÙÀÌ·¯½º.
  • live vaccine virus
    »ý¹é½Å¹ÙÀÌ·¯½º.
  • hoof and mouth disease =foot and mouth d.
    ±¸Á¦(¿ª)(Ï¢ð´æ¹) º´.
  • papilomatosis of Gougerot and Carteaud => confluent and reticulated pa
  • canine hepatitis virus
    °³°£¿°¹ÙÀÌ·¯½º
  • delta (¥ä) hepatitis virus
    µ¨Å¸°£¿°¹ÙÀÌ·¯½º
  • hepatitis A virus(HAV)
    AÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis A virus (HAV)
    AÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis B virus(HBV)
    BÇü °£¿°¹ÙÀÌ·¯½º
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Infectious cause (Virus)
    °¨¿°¿øÀÎ
    [¿¾ ¿ë¾î] °¨¿°¼º¿øÀÎ
  • Tendon sheath of abductor longus and extenor brevis
    ±ä¾öÁö¹ú¸²±Ù°úªÀº¾öÁöÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] À幫Áö¿ÜÀü±Ù ¹× ´Ü¹«Áö½Å±Ù°ÇÃÊ
  • Lymph nodes of head and neck
    ¸Ó¸® ¹× ¸ñ¸²ÇÁÀý
    [¿¾ ¿ë¾î] µÎ°æºÎÀÓÆÄÀý
  • White matter (Tracts and Fascicles)
    ¹é»öÁú(½Å°æ·Î¿Í ½Å°æ´Ù¹ß)
    [¿¾ ¿ë¾î] ¹éÁú
  • Fold and fossa
    º¹¸·ÁÖ¸§°ú º¹¸·¿À¸ñ
    [¿¾ ¿ë¾î] º¹¸·ÁÖ¸§°ú º¹¸·¿Í
  • Tendon sheath of extensor digitorum and extensor indicis
    ¼Õ°¡¶ôÆï±Ù°úÁý°ÔÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] Áö½Å±Ù ¹× ½ÃÁö½Å±Ù°ÇÃÊ
  • Sections of thalamus and metathalamus
    ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
    [¿¾ ¿ë¾î] ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
  • Tracts and fascicles of thalamus
    ½Ã»óÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»ó·Î ¹× ½Ã»ó¼Ó
  • Tracts and fascicles of hypothalamus
    ½Ã»óÇϺÎÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»óÇϺηΠ¹× ½Ã»óÇϺμÓ
  • Period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÈÄ±â ¹× Ã¼ÀýÇü¼ºÀü±â
  • Medial and inferior surface
    ¾ÈÂÊ¸é ¹× ¾Æ·¡¸é
    [¿¾ ¿ë¾î] ³»Ãø¸é°ú Çϸé
  • Sacral nerves and coccygeal nerve
    ¾ûÄ¡½Å°æ ¹× ²¿¸®½Å°æ
    [¿¾ ¿ë¾î] õ°ñ½Å°æ ¹× ¹Ì°ñ½Å°æ
  • Lobar and segmental bronchi
    ¿±±â°üÁö¿Í ±¸¿ª±â°üÁö
    [¿¾ ¿ë¾î] ¿±±â°üÁö¿Í ±¸±â°üÁö
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³ ¹× ±¸Çù±Ù
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³±Ù ¹× ±¸Çù±Ù
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amebic hepatitis
    ¾Æ¸Þ¹Ù°£¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactivated vaccine
    ºÒȰ¼ºÈ­(ÝÕüÀàõûù) ¹é½Å
  • autogenous vaccine
    ÀÚ°¡(í»Ê«)¹é½Å
  • live vaccine
    »ý(ßæ)¹é½Å
  • mixed vaccine
    È¥¼º(ûèà÷)¹é½Å
  • multivalent vaccine
    ´Ù°¡(Òýʤ) ¹é½Å
  • polyvalent vaccine
    ´Ù°¡(Òýʤ) ¹é½Å
  • hepatitis B surface antigen
    BÇü(úþ) °£¿°(ÊÜæú) Ç¥¸é Ç׿ø(øúØüù÷ê«)
  • type A hepatitis
    AÇü(úþ) °£¿°(ÊÜæú)
  • type B hepatitis
    BÇü(úþ) °£¿°(ÊÜæú)
  • viral hepatitis
    ¹ÙÀÌ·¯½º¼º °£¿° (ÊÜæú)
  • ball and stick model
    °ø ¸·´ë ¸ðµ¨
  • breakage and reunion model
    Àý´ÜÀç°áÇÕ(ï·Ó¨î¢Ì¿ùê)¸ðµ¨
  • cut and patch repair
    Àß¶ó±é±â ¼öº¹(áóÜÖ) (ÔÒ) excision repair
  • Dean and Webb method
    µò°ú¿þºê ¹ý(Ûö)
  • Jacob and Monod hypothesis
    Àð°ö¡¤¸ð³ë ¼³(àã)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatitis B virus
    BÇü °£¿°¹ÙÀÌ·¯½º
  • infectious hepatitis virus
    Àü¿°¼º°£¿°¹ÙÀÌ·¯½º
  • vaccine
    ¹é½Å, ¿ÎÁø
  • enteric virus
    Àå¹ÙÀÌ·¯½º
  • parainfluenza virus
    ÆÄ¶óÀÎÇ÷翣ÀÚ¹ÙÀÌ·¯½º
  • virus
    ¹ÙÀÌ·¯½º
  • fulminant hepatitis
    Àü°Ý¼º°£¿°
  • hepatitis
    °£¿°
  • ball and socket joint
    Àý±¸°øÀ̰üÀý
  • ENT [=ear, nose and throat]
    À̺ñÀÎÈİúÇÐ
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
  • infant and child
    ¿µÀ¯¾Æ, À¯¼Ò¾Æ
  • intake and output
    ¼·Ãë¿Í ¹è¼³
  • kidney ureter and bladder [=KUB]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • KUB [=kidney, ureter and bladder]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IPV inactivated poliomyelitis vaccine or virus; infectious pustular vaginitis; infectious pustular vulvo...
HEV health and environment; hemagglutinating encephalomyelitis virus; hepatitis E virus; hepato-encephal...
HBV hepatitis B vaccine; hepatitis B virus
eIPV enhanced inactivated polio vaccine
Vir virus, viral
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IPV Inactivated Polio-Vaccine
IPV Inactivated poliovirus vaccine
vir Virulence
GBV-C/HGV GB Virus C/Hepatitis G Virus
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hepatitis B virus
    BÇü °£¿° ¹ÙÀÌ·¯½º
    1. BÇü °¨¿° ȯÀÚ¿¡¼­ ¸ðµç ü¾× ³»·Î ¹æÃâµÇ´Â ¹ÙÀÌ·¯½º. 2. »ç¶÷ÀÇ °£¿¡ »ì¸ç, Ç÷û °£¿° µîÀ» ÀÏÀ¸Å°´Â ¹ÙÀÌ·¯½º. HB ¹ÙÀÌ·¯½º¶ó°íµµ ÇÑ´Ù. HBs Ç׿ø, HBc Ç׿ø, HBe Ç׿ø µî ¼¼ Á¾·ùÀÇ Ç׿ø ´Ü¹éÁúÀ» Áö´Ñ ¹ÙÀÌ·¯½ºÀÌ´Ù. ÀÌ °¡¿îµ¥ HBs Ç׿ø¿¡´Â º¹¼öÀÇ Ç׿ø °áÁ¤±â°¡ ÀÖ¾î, ±× ¦¸ÂÃã¿¡ µû¶ó BÇü °£¿° ¹ÙÀÌ·¯½º´Â adr, adw, ayr, aywÀÇ 4°¡Áö ¾ÆÇüÀ¸·Î ³ª´©¾îÁ® ÀÖ´Ù. 1965³â ¹Ì±¹ÀÇ S. ºí·³¹ö±×°¡ ¿À½ºÆ®·¹Àϸ®¾Æ ¿øÁÖ¹ÎÀÇ Ç÷û¿¡¼­ ¹ß°ßÇÏ¿© ´çÃÊ¿¡´Â Ç׿ø¼ºÀÌ ÀÖ´Â ¹°ÁúÀ̶ó°í º¸°í, HB Ç׿ø ¶Ç´Â ¿À½ºÆ®·¹Àϸ®¾Æ Ç׿øÀ̶ó°í ºÒ·¶´Ù. ±× ÈÄ DNA
  • infectious hepatitis virus
    Àü¿°¼º °£¿° ¹ÙÀÌ·¯½º
  • anticaries vaccine
    Ç׿ì½Ä ¿ÎÁø
  • antiplaque vaccine
    Ç×ġŠ¿ÎÁø
  • cholera vaccine
    ÄÝ·¹¶ó ¹é½Å
    ºÒȰ¼ºÈ­ cholerarbsÀ» »ç¿ëÇÑ cholera¿ë ¹é½Å. Á¢Á¾À» ÇØµµ °¨¿° ¿¹¹æ·ÂÀº ºÒÃæºÐÇÏ¿© ¿ÏÀüÇÑ È¿°ú´Â ±â´ëÇÒ ¼ö ¾ø´Ù.
  • corresponding vaccine
    µ¿Á¾ ±Õ ¹é½Å
  • herpes type I vaccine
    Á¦1Çü Æ÷Áø ¹é½Å
  • influenza vaccine
    ÀÎÇ÷翣ÀÚ ¹é½Å
    ÀÎÇ÷翣ÀÚÀÇ ¿¹¹æ¿¡ ¾²ÀÌ´Â ¹é½Å. ´Þ°¿ ¹è¾ç¿¡ ÀÇÇØ Áõ½Ä½ÃŲ ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º¿¡¼­ ´Þ°¿ ¼ººÐÀ» Á¦°ÅÇϰí, Æ÷¸£¸»¸°À» °¡ÇØ °¨¿°·ÂÀ» ¾ø¾Ø °ÍÀÌ´Ù. À¯ÇàÇÏ´Â ¹ÙÀÌ·¯½ºÀÇ Çü°ú ¹é½ÅÀÇ ¹ÙÀÌ·¯½ºÀÇ ÇüÀÌ ¸ÂÁö ¾ÊÀ¸¸é È¿°ú°¡ ÀûÀ¸¹Ç·Î, Ç×»ó ÃÖ±Ù¿¡ À¯ÇàÇÑ 2¡­3°³ À¯ÇüÀÇ »õ·Î¿î ¹ÙÀÌ·¯½º·Î Á¦Á¶µÈ´Ù. Á¦Ç°Àº ¹«»ö Åõ¸íÇÑ ¾×À¸·Î, ¹ÐºÀÇÏ¿© 2¡­5 ¡É¿¡¼­ º¸Á¸µÈ´Ù. À¯È¿ ±â°£Àº °ËÁ¤ ÇÕ°ÝÇÑ ³¯·ÎºÎÅÍ 1³â 6°³¿ùÀ̸ç, 1ȸÀÇ ¾çÀº 15¼¼ ÀÌ»óÀº 0.5 cc, 6¡­15¼¼ ¹Ì¸¸Àº 0.3 cc, 1¡­6¼¼ ¹Ì¸¸Àº 0.2 cc, 1¼¼ ¹Ì¸¸Àº 0.1 ccÀÌ´Ù. ºÎÀÛ¿ëÀº Áֻ縦 ¸ÂÀº ÀÚ¸®°¡ ¾à°£ º×°í ¾ÆÇÁ°Å³ª, ÀϽÃÀûÀÎ ¹ß¿­À̳ª °¡º­¿î °¨±â Áõ¼¼°¡ ³ªÅ¸³¯ ¼ö Àִµ¥, ¿°·ÁÇÒ °ÍÀº ¸ø µÈ´Ù. ´Ù¸¸, ´Þ°¿ ¾Ë·¹¸£±âÀÎ »ç¶÷Àº Áֻ縦 ÇÇÇϰí, Áöº´ÀÌ ÀÖ´Â »ç¶÷Àº ÀÇ»ç¿Í »ó´ãÇÑ´Ù. ¿¹¹æ Á¢Á¾ÀÇ È¿°ú´Â ÁÖ»ç ÈÄ 2ÁÖ°£ÀÌ Áö³ª¾ß ³ªÅ¸³ª¸ç, 3¡­6°³¿ù °£ Áö¼ÓÇϹǷÎ, ¸Å³â À¯Çà±â¿¡ ¾Õ¼­ 10¡­11¿ù¿¡ Áֻ縦 ¸Â´Â °ÍÀÌ ÁÁ´Ù.
  • killed vaccine
    »ç¹é½Å
  • live vaccine
    »ý ¹é½Å
  • mixed vaccine
    È¥ÇÕ ¹é½Å
    µÎ Á¾·ù ÀÌ»óÀÇ ¿¹¹æÁ¢Á¾ Àç·á¸¦ È¥ÇÕÇÑ ¹é½Å. È¥ÇÕÇÔÀ¸·Î½á °¢ ¼ººÐÀÇ ¸é¿ª¿ø¼º¿¡ °¨¼ÕÀÌ ¾ø´Â °æ¿ì ÇàÇÏ¿©Áø´Ù. °¡Àå º¸ÆíÀûÀ¸·Î ¾²À̰í ÀÖ´Â °Í¿¡´Â ÀåÆ¼Çª½º¿Í ÆÄ¶óƼǪ½ºÀÇ È¥ÇÕ ¹é½Å, ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½ºÀÇ AÇü°ú BÇüÀÇ È¥ÇÕ ¹é½Å µîÀÌ ÀÖ´Ù. ÀåÆ¼Çª½º, ÆÄ¶óƼǪ½º È¥ÇÕ ¹é½ÅÀº ÀåÆ¼Çª½º±Õ°ú A±Õ ¹× ÆÄ¶óƼǪ½º B±ÕÀ» »ì±ÕÇÏ¿© ÀÏÁ¤ÇÑ ºñÀ²·Î È¥ÇÕÇÑ °ÍÀ¸·Î¼­, ÇÇÇÏ ÁÖ»ç ¶Ç´Â Çdz» ÁÖ»çÇÑ´Ù.
  • Nicolle-Blaizot's vaccine
    ´ÏÄÝ, ºí·¹ÀÌÁ¶ ¿ÎÁø
    ÀÓ±ÕÀ¸·Î ¸¸µç ÀÓÁú ¿ÎÁø.
  • oral poliovirus vaccine
    ¼Ò¾Æ¸¶ºñ °æ±¸ ¹é½Å, Æú¸®¿À °æ±¸ ¹é½Å
  • polio vaccine
    ¼Ò¾Æ ¸¶ºñ ¹é½Å
    ¼Ò¾Æ ¸¶ºñÀÇ ¿¹¹æÀ» À§ÇÏ¿© ¾²ÀÌ´Â ¸é¿ª¿ø.
  • rabies vaccine
    ±¤°ßº´ ¹é½Å
    ±¤°ßº´ÀÇ ¹ßº´°ú ¿¹¹æÀ» ¸ñÀûÀ¸·Î °³¹ßµÈ ¹é½Å. 1884³â ÇÁ¶û½ºÀÇ L. ÆÄ½ºÅ𸣰¡ ¼§º£¸¦¶û
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
inactivated polio vaccine <pharmacology, virology> An inactivated vaccination, administered by injection to children for protection against the polio virus. Typically given at 2, 4 and 15 months. A final vaccine is recommended at 4-6 years.
(27 Sep 1997)
inactivated poliovirus vaccine Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine.
See: Salk vaccine.
(05 Mar 2000)
vaccines, inactivated Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.
(12 Dec 1998)
inactivated serum <immunology> Serum that has been heated 50°C for 30 minutes to destroy the lytic activity of complement.
(05 Mar 2000)
hepatitis B vaccine <virology> An injectable vaccine, given in three boosters, which offers protection from infection with hepatitis B.
(27 Sep 1997)
measles, mumps and rubella vaccine A combination of live attenuated measles, mumps, and rubella viruses in an aqueous suspension; used for immunization against the respective diseases.
(05 Mar 2000)
typhoid-paratyphoid A and B vaccine A suspension of killed typhoid and paratyphoid A and B bacilli.
See: typhoid vaccine.
Synonym: TAB vaccine.
(05 Mar 2000)
measles virus vaccine Vaccine containing live, attenuated strains of measles virus prepared in chick embryo cell culture.
See: measles, mumps, and rubella vaccine.
(05 Mar 2000)
rubella virus vaccine A live virus vaccine prepared from duck embryo or human diploid cell culture infected with rubella virus; administered as a single subcutaneous injection.
See: measles, mumps, and rubella vaccine.
(05 Mar 2000)
mumps virus vaccine Vaccine containing live, attenuated mumps virus prepared in chick embryo cell cultures.
See: measles, mumps, and rubella vaccine.
(05 Mar 2000)
split-virus vaccine <pharmacology> A vaccine composed of a purified antigenic determinant that is separated from the disease-causing organism.
(06 Mar 1998)
hepatitis d, e, f, and g Lesser known (than hepatitis a, b, and c), the most significant of these seems to be type d, or the delta agent, which only causes disease in the presence of the hepatitis b virus.
(12 Dec 1998)
anicteric virus hepatitis A relatively mild hepatitis, without jaundice, due to a virus; the principal physical signs and symptoms are enlargement of the liver, lymph nodes, and often the spleen, together with headache, continuous fatigue, nausea, anorexia, sudden distaste for smoking, abdominal pains, and sometimes mild fever; labratory tests reveal evidence of hepatitis.
(05 Mar 2000)
virus A hepatitis A virus disease with a short incubation period (usually 15 to 50 days), caused by hepatitis A virus, a member of the family Picornaviridae, often transmitted by faecal-oral route; may be inapparent, mild, severe, or occasionally fatal and occurs sporadically or in epidemics, commonly in school-age children and young adults; necrosis of periportal liver cells with lymphocytic and plasma cell infiltration is characteristic and jaundice is a common symptom.
Synonym: epidemic hepatitis, hepatitis A, infectious hepatitis, MS-1 hepatitis, short incubation hepatitis, virus A hepatitis.
(05 Mar 2000)
virus B hepatitis A virus disease with a long incubation period (usually 50 to 160 days), caused by hepatitis B virus, a DNA virus and member of the family Hepadnoviridae, usually transmitted by injection of infected blood or blood derivatives or by use of contaminated needles, lancets, or other instruments; clinically and pathologically similar to viral hepatitis type A, but there is no cross-protective immunity; HBsAg is found in the serum and the hepatitis delta virus occurs in some patients.
Synonym: hepatitis B, serum hepatitis, transfusion hepatitis, virus B hepatitis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vaccine
    ¿ìµÎÁ¾
  • Sabin vaccine
    ¼¼À̺ó ¹é½Å(¼Ò¾Æ¸¶ºñ »ý ¹é½Å)
  • Salk vaccine
    ¼ÒÅ©¹é½Å(¼Ò¾Æ¸¶ºñ ¿¹¹æ¿ë)
  • hepatitis
    °£¿°
  • hepatitis A
    AÇü °£¿°;Àü¿°¼º(Ç÷û)°£¿°
  • vaccine
    ¿ìµÎÁ¾;¹é½Å
  • virus
    ¹ÙÀÌ·¯½º
  • C-type virus
    CÇü ¹ÙÀÌ·¯½º(¹ß¾Ï¼ºÀ¸·Î ¿©°ÜÁö°í ÀÖÀ½)
  • EpsteinBarr virus
    ¿¦½ºÅ¸ÀÎ ¹Ù ¹ÙÀÌ·¯½º
  • Friend virus
    ÇÁ·»µå ¹ÙÀÌ·¯½º
  • filamentous virus
    ¼¶»ç»ó ¹ÙÀÌ·¯½º
  • filterable virus
    ¿©°ú¼º ¹ÙÀÌ·¯½º(º´¿øÃ¼)
  • parainfluenza virus
    ÆÄ¶óÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º(»ç¶÷,¸¶¼Ò,µÅÁö µî¿¡ È£Èí ÁúȯÀ» ÀÏÀ¸Å´)
  • polyoma virus
    Æú¸®¿À¸¶ ¹ÙÀÌ·¯½º
  • virus
    ¹ÙÀÌ·¯½º;¿©°ú¼º º´¿øÃ¼;(Á¤½Å,µµ´ö»óÀÇ)ÇØµ¶
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á